StonvexLoading…
StonvexStonvexStonvexCore line items from UWMC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $901.43M | $3.16B | $2.22B | $1.37B |
Operating Income | $177.50M | $250.90M | $81.27M | $68.60M |
Net Income | $25.30M | $27.38M | $7.97M | $9.23M |
EPS (Diluted) | $0.09 | $0.12 | $0.04 | $0.03 |
Total Assets | $19.27B | $16.93B | $17.02B | $13.89B |
Total Liabilities | $17.67B | $15.34B | $15.44B | $12.14B |
Cash & Equivalents | $424.00M | $503.36M | $870.70M | $489.98M |
Free Cash Flow OCF − CapEx | $-2.25B | $-2.72B | $-2.80B | $286.07M |
Shares Outstanding | 1.60B | 1.60B | 1.60B | 1.60B |